Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00789893 · ClinicalTrials.gov registry record
Study of Vaginal Dilator Use After Pelvic Radiotherapy
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 115
- Enrollment target
NCT00789893: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00789893 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 115 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00789893 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 115 participants
- Enrollment target
Study Summary
Patient will have radiation to treat the cancer. This treatment can make the vagina both narrower and shorter. That can cause two problems. It can make it harder for the doctor to do a pelvic exam during a follow-up visits. And, it can make sexual intercourse uncomfortable. We tell women to use a vaginal dilator after radiation to the pelvis. This is standard education. We do not routinely ask women how they do with it. We are doing this study to see if using the dilator as we instruct will help the vagina stretch. The patient will have an examine of the vagina before the start of radiation. We will see what size dilator can fit. The goal of this study is to have the patient be able to use that size dilator within six months after radiation.
Interventions
- DEVICE Vaginal Dilator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2008-11 |
| Est. Completion | 2015-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00789893
The ClinicalTrials.gov registry entry for NCT00789893 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vaginal Dilator is the first listed.
NCT00789893 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00789893 about?
NCT00789893 is a clinical study titled "Study of Vaginal Dilator Use After Pelvic Radiotherapy". Patient will have radiation to treat the cancer. This treatment can make the vagina both narrower and shorter. That can cause two problems. It can make it harder for the doctor to do a pelvic exam during a follow-up visits. And, it can make sexual intercourse uncomfortable. We tell women to use a v...
What is the current status of trial NCT00789893?
This trial is currently completed. The enrollment target is 115 participants. The study started on 2008-11. Estimated completion is 2015-06.
What interventions are being tested in trial NCT00789893?
The interventions under investigation include: Vaginal Dilator (DEVICE).
Who is sponsoring clinical trial NCT00789893?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.